Share via:
PharmEasy’s subsidiary Docon Technologies has offloaded 53.3 Lakh equity shares or about 10% stake in listed subsidiary Thyrocare via a bulk deal
The company raked in a total of INR 667.7 Cr share via the block deal, which valued each share at INR 1,252.03
Following this transaction, PharmEasy’s ownership in Thyrocare will reduce to 60.93% from the 70.98% stake it held previously
Distressed healthtech startup PharmEasy’s subsidiary Docon Technologies has offloaded…
We strive to uphold the highest ethical standards in all of our reporting and coverage. We StartupNews.fyi want to be transparent with our readers about any potential conflicts of interest that may arise in our work. It’s possible that some of the investors we feature may have connections to other businesses, including competitors or companies we write about. However, we want to assure our readers that this will not have any impact on the integrity or impartiality of our reporting. We are committed to delivering accurate, unbiased news and information to our audience, and we will continue to uphold our ethics and principles in all of our work. Thank you for your trust and support.
PharmEasy’s subsidiary Docon Technologies has offloaded 53.3 Lakh equity shares or about 10% stake in listed subsidiary Thyrocare via a bulk deal
The company raked in a total of INR 667.7 Cr share via the block deal, which valued each share at INR 1,252.03
Following this transaction, PharmEasy’s ownership in Thyrocare will reduce to 60.93% from the 70.98% stake it held previously
Distressed healthtech startup PharmEasy’s subsidiary Docon Technologies has offloaded…
We strive to uphold the highest ethical standards in all of our reporting and coverage. We StartupNews.fyi want to be transparent with our readers about any potential conflicts of interest that may arise in our work. It’s possible that some of the investors we feature may have connections to other businesses, including competitors or companies we write about. However, we want to assure our readers that this will not have any impact on the integrity or impartiality of our reporting. We are committed to delivering accurate, unbiased news and information to our audience, and we will continue to uphold our ethics and principles in all of our work. Thank you for your trust and support.
Website Upgradation is going on for any glitch kindly connect at office@startupnews.fyi
